glp 1 economist Could weight-loss drugs eat the world? It's not just obesity. Drugs

Prescription rates of SGLT2 inhibitors and GLP-1 receptor agonists among adults with type 2 diabetes in the Veterans Health Administration varied by race, with white patients most likely to receive these medications

While natural approaches to raising GLP-1 are not as potent as medications, they provide a drug-free approach to weight loss and healthy eating.

This Sunday's issue of Plain Medicine breaks down who qualifies, how to access the benefit, and what to ask your provider before July 1

Materials and Methods We used mathematical modeling and simulation of semaglutide and tirzepatide

Tirzepatide, characterized by its ability to selectively bind and activate receptors for the intestinal hormones GIP and GLP-1, has been tested in numerous clinical studies and is already currently authorized in several countries for the treatment of type 2 diabetes and obesity